Zobrazeno 1 - 3
of 3
pro vyhledávání: '"MESH: HIV Infections/blood"'
Autor:
Pierre Gantner, Laurent Cotte, Clotilde Allavena, Firouzé Bani-Sadr, Thomas Huleux, Claudine Duvivier, Marc-Antoine Valantin, Christine Jacomet, Véronique Joly, Antoine Chéret, Pascal Pugliese, Pierre Delobel, André Cabié, David Rey, Dat’AIDS Study Group
Publikováno v:
PLoS ONE
PLoS ONE, 2019, 14 (4), pp.e0215464. ⟨10.1371/journal.pone.0215464⟩
PLoS ONE, Public Library of Science, 2019, 14 (4), pp.e0215464. ⟨10.1371/journal.pone.0215464⟩
PLoS ONE, Vol 14, Iss 4, p e0215464 (2019)
PLoS ONE, 2019, 14 (4), pp.e0215464. ⟨10.1371/journal.pone.0215464⟩
PLoS ONE, Public Library of Science, 2019, 14 (4), pp.e0215464. ⟨10.1371/journal.pone.0215464⟩
PLoS ONE, Vol 14, Iss 4, p e0215464 (2019)
IntroductionAchieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B surface antigen [Anti-HBs]) in individuals with HIV and HBV infections is a rare eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2c879522156128d87ef13694d8d2319
https://hal.sorbonne-universite.fr/hal-02110275
https://hal.sorbonne-universite.fr/hal-02110275
Autor:
François Raffi, Jean-Michel Molina, Christine Katlama, Marie-Laure Chaix, Juliette Saillard, Minh Patrick Lê, Gilles Peytavin, Sylvie Chevret, Sebastien Gallien, Yazdan Yazdanpanah, Pierre Delobel
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 2019, 85 (1), pp.277-280. ⟨10.1111/bcp.13796⟩
British Journal of Clinical Pharmacology, 2019, 85 (1), pp.277-280. ⟨10.1111/bcp.13796⟩
International audience; A key concern for reduced-dose antiretroviral regimens in maintenance strategies in HIV-infected patients is virological efficacy, as assessed by the suppression of HIV-RNA in blood and reservoirs, such as the genital tract. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15d0799604e0f88f57976c2ef0ea70a0
https://ut3-toulouseinp.hal.science/hal-03639183
https://ut3-toulouseinp.hal.science/hal-03639183
Autor:
Josiane Warszawski, Véronique Avettand-Fenoel, Stéphane Blanche, Jérôme Le Chenadec, Jean-Paul Viard, Naima Bouallag, Yves Rivière, Florence Buseyne, Daniel Scott-Algara, Christine Rouzioux, Catherine Dollfus, Yassine Benmebarek
Publikováno v:
Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2012, 205 (10), pp.1520-1528. ⟨10.1093/infdis/jis233⟩
Journal of Infectious Diseases, 2012, 205 (10), pp.1520-1528. ⟨10.1093/infdis/jis233⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2012, 205 (10), pp.1520-1528. 〈10.1093/infdis/jis233〉
Journal of Infectious Diseases, Oxford University Press (OUP), 2012, 205 (10), pp.1520-1528. ⟨10.1093/infdis/jis233⟩
Journal of Infectious Diseases, 2012, 205 (10), pp.1520-1528. ⟨10.1093/infdis/jis233⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2012, 205 (10), pp.1520-1528. 〈10.1093/infdis/jis233〉
Background. Our aim was to study the impact of lifelong human immunodeficiency virus (HIV) disease history on the current immune and virological status of perinatally infected patients reaching adulthood. We evaluated blood cell–associated HIV DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd419eb05d99fa6a4fd79420612684d5
https://hal-pasteur.archives-ouvertes.fr/pasteur-01418092/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-01418092/document